Sonoma Pharmaceuticals (SNOA) Debt to Equity (2016 - 2022)
Sonoma Pharmaceuticals (SNOA) has 2 years of Debt to Equity data on record, last reported at $0.5 in Q4 2012.
- For Q4 2012, Debt to Equity fell 97.49% year-over-year to $0.5; the TTM value through Dec 2012 reached $0.5, down 97.49%, while the annual FY2012 figure was -$2.16, 286.44% down from the prior year.
- Debt to Equity reached $0.5 in Q4 2012 per SNOA's latest filing, up from -$5.13 in the prior quarter.
- Across five years, Debt to Equity topped out at $19.84 in Q4 2011 and bottomed at -$13.38 in Q3 2011.